Viela Bio
company
Exit Type
M&A
Exit Date
Oct 2, 2019
Exit parties in this round
| Partner | Fund Round | Return Amount | Return Multiplier | |
|---|---|---|---|---|
| AstraZeneca | Series E | — | — | Detail |
